Healthcare

CytoDyn to Prepare a Phase 3 Protocol to Submit to the FDA for a Three-Arm Comparative and Combination Trial of Leronlimab and Remdesivir

VANCOUVER, Washington, May 18, 2020 — Three arms of this trial will be leronlimab, remdesivir, and leronlimab + remdesivir CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), […]

Newsmakers

Live Sports Are Back on fuboTV (OTC: FUBO)

As the world continues to be impacted by the COVID-19 pandemic, there are positive signs life is returning to normal – including the return of live sports. FaceBank Group, Inc. (d/b/a fuboTV) (OTCQB: FUBO) kicks […]

Healthcare

CytoDyn (OTC: CYDY) to Offer No-Cost Exploratory Laboratory Testing for Childhood Inflammatory Disease Associated with COVID-19

VANCOUVER, Washington, May 15, 2020– CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced it is […]

Newsmakers

CytoDyn Completed Submission of All Remaining Parts of Biologics License Application (“BLA”) on May 11, 2020

VANCOUVER, Washington, May 13, 2020 — CytoDyn Submits Requested Datasets to FDA for Biologics License Application CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist […]

Newsmakers

NexTech (OTC: NEXCF) Integrates Microsoft Teams and Skype into its InfernoAR Virtual Events platform

Expanding its footprint into Multi-billion dollar Video Conferencing market NEW YORK and TORONTO, May 12, 2020 — NexTech AR Solutions (NexTech) (NEXCF) (CSE:NTAR) (N29.F), an emerging leader in augmented reality for eCommerce, AR learning applications, and virtual […]

Newsmakers

ImagineAR (OTC: IPNFF) Announces Partnership with Engaged Nation, An Award Winning Leader In Digital Engagement Marketing For Casinos

Engaged Nation Services Many Top Casinos in North America VANCOUVER and ERIE, PA , May 12, 2020 – ImagineAR (IP:CSE) (IPNFF:OTCQB)) an Augmented Reality Company that enables businesses to create their own mobile phone AR campaigns, is pleased […]

Newsmakers

fuboTV (OTC: FUBO) Co-founder & CEO David Gandler To Be Interviewed By Canaccord Genuity Analyst Maria Ripps on Video Webcast for Investors on May 11, 2020

Facebank Group, Inc. d/b/a fuboTV (OTCQB: FUBO) announced today that Co-founder & CEO David Gandler will be featured on a video webcast hosted by Canaccord Genuity analyst Maria Ripps on May 11, 2020. The presentation […]

Newsmakers

Manuscript Describes How CytoDyn’s (OTC: CYDY) Leronlimab Disrupts CCL5/RANTES-CCR5 Pathway, Thereby Restoring Immune Homeostasis, Reducing Plasma Viral Load, Reversing Hyper Immune Activation and Inflammation in Critical COVID-19 Patients

VANCOUVER, Washington, May 06, 2020 (GLOBE NEWSWIRE via COMTEX) — Manuscript Posted Online to Research Square and MedRxiv Pre-print Server CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO […]

Healthcare

Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn (OTC: CYDY) for Drug Product Used in COVID-19 Clinical Trials

SAN DIEGO, May 5, 2020  —- Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing services agreement with CytoDyn Inc., […]

Newsmakers

fuboTV Announces Ticker Symbol Change To (OTC: FUBO)

FaceBank Group, Inc. (d/b/a fuboTV) announced today that the company’s ticker symbol on the OTCQB has changed to “FUBO” from “FBNK” effective tomorrow at market open. The number of shares outstanding of the registrant’s common […]

Healthcare

CytoDyn (OTC: CYDY) Reports Strong Results from eIND COVID-19 Patients Treated with Leronlimab; Majority of Patients Have Demonstrated Remarkable Recoveries

54 eINDs approved by FDA and 49 patients have been treated with leronlimab thus far VANCOUVER, Washington, Apr 30, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab […]